--2025/Q1-- / 13.200M--
--2024/Q4-- / 15.122M--
Nov 5, 20242024/Q314.269M / 14.132M--
--2024/Q211.772M / 13.047M--
--2024/Q17.410M / 14.664M--
US Stock MarketDetailed Quotes
BEAM Beam Therapeutics
- 26.620
- +2.690+11.24%
Close Nov 6 16:00 ET
- 26.120
- -0.500-1.88%
Post 17:25 ET
2.20BMarket Cap-16848P/E (TTM)
27.300High25.240Low2.02MVolume26.000Open23.930Pre Close53.24MTurnover2.98%Turnover RatioLossP/E (Static)82.81MShares49.50052wk High2.79P/B1.81BFloat Cap18.85052wk Low--Dividend TTM67.88MShs Float138.522Historical High--Div YieldTTM8.61%Amplitude13.000Historical Low26.354Avg Price1Lot Size
Beam Therapeutics Key Stats
Beam Therapeutics Q3 2024 Earnings Date
Currency：USDNov 5, 2024
| Estimate (YoY) |
Actual (YoY) |
Vs Estimate (% Chg) |
|
| Revenue |
14.13M
|
14.27M
|
+137.03K
|
| Beat Est. |
-17.80%
|
-17.01%
|
+0.97%
|
| EPS |
-1.15
|
-1.17
|
-0.02
|
| Miss Est. |
+6.12%
|
+4.10%
|
-2.17%
|
Analyst Rating
Nov 6, 2024
Beam Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Beam Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
